Growing evidence supports the role of increased HMGA2 expression in CRC progression and metastasis, which suggests HMGA2 may be a prognostic marker of poor patient prognosis, as it is a critical regulator of various signaling pathways [119]. The gene discussed is HMGA2; the disease is colorectal carcinoma.